Print this page    •   Back to Web version of article

Medical News
FDA: Abbott Recalls Some HIV Blood Screening Tests

September 13, 2010

The Food and Drug Administration said Thursday that Abbott Laboratories has recalled some HIV blood tests after customers complained of "calibration failures." Approved by FDA almost a year ago, the Prism HIV O Plus test is used by laboratory professionals. Abbott says it is the first fully automated blood screening test for HIV-1 and HIV-2. Abbott spokesperson Don Braakman said the company knows of no effect on blood donations or the supply of blood products. The company notified its customers and FDA of the problem last week and already has replaced the lot in question, he added. The recalled tests carry lot number 87334M500. FDA said customers who have an alternate supply of the product should stop using the recalled lot and discard it. Customers with no alternate supply should continue using the recalled lot until replacement tests arrive. For more information, visit www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/Recalls/ucm225303.htm.

Back to other news for September 2010

Excerpted from:
Dow Jones Newswires
09.09.2010; Peter Loftus




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art58438.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.